Given that ATM is mutated or lost in over 40% of MCL [51], we and others examined the effects of ATM loss on PARP inhibitor sensitivity in human lymphoma cell lines that lack ATM protein expression. The gene discussed is ATM; the disease is mantle cell lymphoma.